Plant Health Care protects crops by stimulating their immune system
- Plant Health Care wins approval for Harpin fertiliser in Argentina
- Plant Health Care's ground-breaking new technology targets US$5bn opportunity
- Plant Health Care says new US OTC market listing is 'start of something very exciting'
Quick facts: Plant Health Care PLC
Price: 12.55 GBX
Market Cap: £37.95 m
About the company
Plant Health Care is a leading provider of scientifically proven biological products for the agricultural industry. The company offers products to improve the health, vigor and yield of major field crops such as corn, soybeans, cotton and rice, as well as specialty crops such as fruits and vegetables.
Our innovative line of patent protected products provides both economic and environmental benefits for our customers and capitalizes upon long-term trends towards natural systems and biological solutions to promote plant health and growth.
How it is doing
Senasa, the country’s food safety regulator, classified it as a biostimulant organic-chemical fertiliser. Corn and soybeans will be the first crops allowed to receive Harpin.
Argentina has 24mln hectares of corn and soybeans planted in the current season and growers spent more than US$100mln on soybean seed treatments in the previous one.
The size of the biological market in soybeans is growing rapidly and was about US$75mln in 2021, the AIM-listed group noted.
Plant Health Care PLC (AIM:PHC) has landed a new distribution agreement with Agrii, described as a leading distributor in the UK, which gains exclusive access to the company’s biostimulant, Harpin α, in all crops in the UK.
The company said that Harpin α has exceptional grower benefits for those in the UK, particularly in the amenity (turf) market and in potatoes. It has been sold on a small scale in the UK previously, under the ProAct brand name.
The provider of scientifically proven biological products for the agricultural industry said revenue for the six months ended June 30 was up 13% at U$3.5mln.
Insight: Plant Health Care's ground-breaking new technology targets US$5bn opportunity
Its technologies are designed to “stimulate the immune system of plants,” says chief executive, Dr Christopher Richards, trying to keep things reasonably high level for me. “Think of them as vaccines for plants,” he continues.
What management says
Plant Health Care PLC (AIM:PHC)'s (LON:PHC) Christopher Richards talks to Proactive London's Katie Pilbeam about their plans to commence trading on the US OTCQB Venture Market which he says is 'start of something very exciting'.
Richards explains how the US market represents the single largest opportunity for Plant Health Care products.
He also discusses their first-half sales of their lead product as 'encouraging' with revenue for the six months ended June 30 was up 13% at U$3.5mln.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...FOR OUR FULL DISCLAIMER CLICK HERE